Institute for Advancing Translational Medicine in Bone & Joint Diseases (TMBJ), Suzhou Ribo Life Science Co., Ltd. (Suzhou Ribo) and Kunshan RNAi Institute (KSRI) held a seminar about further research and development on CKIP-1 siRNA in Kunshan on June 20, 2013. Dr. Ge Zhang from TMBJ, Prof. Zicai Liang and Office Director Mr. Shaolin Cheng from KSRI, General Manager Ms. Hongyan Zhang, Vice General Manager Ms. Yi Jin and Inspector General Mr. Shan Gao from Suzhou Ribo, and other researchers attended the seminar.

Dr. Ge Zhang gave a brief introduction to the  research work and recent achievement in TMBJ. Dr. Xiaojuan He made a progress report on the project: 'the role of CKIP-1 in bone metabolism in rheumatoid arthritis'. Inspector General Mr. Shan Gao and Dr. Yuanyu Huang from Suzhou Ribo introduced a novel targeted delivery vector and technology research platform on siRNA drugs, respectively.

All research participants had warm discussions on further researches and developments of CKIP-1 siRNA in rheumatoid arthritis therapy. Dr. Ge Zhang, Prof. Zicai Liang, Ms. Hongyan Zhang and Mr. Shan Gao also made detailed schedules for future cooperation.

Representatives from TMBJ, Suzhou Ribo and KSRI in the seminar